The vaccine was evaluated by the European Medicines Agency under its accelerated assessment mechanism.

CDC guidance changes at behest of the White House.

SARS-CoV-2 genetic material remains detectable in postmortem respiratory tract.

Already described data from a randomized trial now vetted through peer review.

At least 80 million under one year of age are at risk as COVID-19 disrupts routine vaccinations.

Hydroxychloroquine, chloroquine with or without macrolide yielded worse outcomes.

AI performs better than clinicians, even when CT results are normal.

The CDC has also published different COVID-19 outbreak scenarios that have drawn criticism.

Inflammation markers are independently associated with mortality risk.

The CDC has published a case definition of the Kawasaki-like disease striking children.

Tool could aid in risk estimation for patients with COVID-19.

In young patients of Asian ancestry, BMI might inform triage decisions.

An accompanying editorial calls for caution.

Symptom is most common among younger patients.